Pluripotent Stem Cell-Based Cell Therapy-Promise and Challenges
- PMID: 33007237
- DOI: 10.1016/j.stem.2020.09.014
Pluripotent Stem Cell-Based Cell Therapy-Promise and Challenges
Abstract
Human pluripotent stem cells such as embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) provide unprecedented opportunities for cell therapies against intractable diseases and injuries. Both ESCs and iPSCs are already being used in clinical trials. However, we continue to encounter practical issues that limit their use, including their inherent properties of tumorigenicity, immunogenicity, and heterogeneity. Here, I review two decades of research aimed at overcoming these three difficulties.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Interests S.Y. is an inventor of patents about iPSC technology. S.Y. is a scientific advisor, without salary, to iPS Academia Japan Inc., which handles licenses of the patents.
Similar articles
-
The use of pluripotent stem cell for personalized cell therapies against neurological disorders.J Biomed Biotechnol. 2011;2011:520816. doi: 10.1155/2011/520816. Epub 2011 Dec 13. J Biomed Biotechnol. 2011. PMID: 22203784 Free PMC article. Review.
-
The application of induced pluripotent stem cells for bone regeneration: current progress and prospects.Tissue Eng Part B Rev. 2014 Aug;20(4):328-39. doi: 10.1089/ten.TEB.2013.0301. Epub 2013 Nov 14. Tissue Eng Part B Rev. 2014. PMID: 24102431 Review.
-
Clinical applications of pluripotent stem cells and their derivatives: current status and future perspectives.Regen Med. 2022 Sep;17(9):677-690. doi: 10.2217/rme-2022-0045. Epub 2022 Jun 15. Regen Med. 2022. PMID: 35703035 Review.
-
Can pluripotent stem cells be used in cell-based therapy?Cell Reprogram. 2014 Apr;16(2):98-107. doi: 10.1089/cell.2013.0072. Epub 2014 Mar 7. Cell Reprogram. 2014. PMID: 24606201 Free PMC article. Review.
-
Induced Pluripotent Stem Cells and Induced Pluripotent Cancer Cells in Cancer Disease Modeling.Adv Exp Med Biol. 2018;1119:169-183. doi: 10.1007/5584_2018_257. Adv Exp Med Biol. 2018. PMID: 30069853 Review.
Cited by
-
The bHLH Transcription Factors in Neural Development and Therapeutic Applications for Neurodegenerative Diseases.Int J Mol Sci. 2022 Nov 11;23(22):13936. doi: 10.3390/ijms232213936. Int J Mol Sci. 2022. PMID: 36430421 Free PMC article. Review.
-
Application of mesenchymal stem/stromal cells in periodontal regeneration: Opportunities and challenges.Jpn Dent Sci Rev. 2024 Dec;60:95-108. doi: 10.1016/j.jdsr.2024.01.001. Epub 2024 Jan 25. Jpn Dent Sci Rev. 2024. PMID: 38314143 Free PMC article. Review.
-
The Immunomodulatory Capacity of Induced Pluripotent Stem Cells in the Post-stroke Environment.Front Cell Dev Biol. 2021 Mar 16;9:647415. doi: 10.3389/fcell.2021.647415. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33796535 Free PMC article. Review.
-
Different origin-derived exosomes and their clinical advantages in cancer therapy.Front Immunol. 2024 Jun 27;15:1401852. doi: 10.3389/fimmu.2024.1401852. eCollection 2024. Front Immunol. 2024. PMID: 38994350 Free PMC article. Review.
-
Application of aptamers in regenerative medicine.Front Bioeng Biotechnol. 2022 Aug 29;10:976960. doi: 10.3389/fbioe.2022.976960. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36105606 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources